A Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma
'UROLIFE': a Patient-Directed Mobile Tool to Streamline the QoL Assessment and Monitoring in Urothelial Carcinoma
IRCCS San Raffaele
50 participants
Jun 30, 2025
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to select contents and tools for the future development of a web app aiming to support patients' navigation for empowering decision-making through a higher awareness of urothelial carcinoma and its treatments, improving also educational aspects. The main question it aims to answer is: What are the contents that patients diagnosed with urothelial carcinoma find useful to include in a web app to streamline their quality of life assessment and monitoring? Participants candidate for systemic treatments, or already under treatment, will answer questionnaires about the tools to include in a web app designed for urothelial carcinoma.
Eligibility
Inclusion Criteria6
- histological diagnosis of urothelial carcinoma;
- ≥ 18 years old,
- candidate for systemic treatment with chemotherapy, immune-checkpoint inhibitors, antibody-drug conjugates, or target therapy (patients can be enrolled also if the treatment has started),
- possession of a mobile device (e.g., smartphone or personal computer) with the physical and psychological ability to use mobile devices,
- understanding and speaking the Italian language,
- ability to sign an informed consent.
Exclusion Criteria2
- not possession of a mobile device,
- unwillingness to give informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06982794